Related Experiment Video
Updated: May 2, 2026

Production and Detection of Reactive Oxygen Species ROS in Cancers
Published on: November 21, 2011
Reactive oxygen species in diabetic nephropathy: friend or foe?
Tzvetanka Bondeva1, Gunter Wolf1
1Department of Internal Medicine III, University Hospital Jena, Jena D-07740, Germany.
Abstract:
Based on the numerous cellular and animal studies over the last decades, it has been postulated that reactive oxygen species (ROS) are important secondary messengers for signalling pathways associated with apoptosis, proliferation, damage and inflammation. Their adverse effects were considered to play a leading role in the onset and progression of type 1 and type 2 diabetes mellitus as well as in the complication of diabetic disease leading to vascular-, cardiac-, neuro-degeneration, diabetic retinopathy and diabetic nephropathy. All these complications were mostly linked to the generation of the superoxide anion, due to a prolonged hyperglycaemia in diabetes, and this anion was almost 'blamed for everything', despite the fact that its measurement and detection in life systems is extremely complicated due to the short lifespan of the superoxide anion. Therefore, a tremendous amount of research has been focused on finding ways to suppress ROS production. However, a recent report from Dugan et al. shed new insights into the life detection of superoxide generation in diabetes and raised the question of whether we treat the diabetes-related complications correctly or the target is somewhat different as thought. This review will focus on some aspects of this novel concept for the role of ROS in diabetic nephropathy.
Insights
Reactive oxygen species (ROS) are implicated in diabetes complications. New research questions the traditional focus on superoxide anion, suggesting a different target for treating diabetic nephropathy.
Area of Science:
- Biochemistry
- Cell Biology
- Endocrinology
Background:
- Reactive oxygen species (ROS) act as signaling molecules in pathways like apoptosis, proliferation, damage, and inflammation.
- Adverse ROS effects are linked to type 1 and type 2 diabetes mellitus onset and progression, including vascular, cardiac, and neurodegenerative complications, diabetic retinopathy, and nephropathy.
- Superoxide anion generation due to hyperglycemia was considered the primary cause of these complications, despite detection challenges.
Purpose of the Study:
- To review the novel concept regarding the role of ROS in diabetic nephropathy.
- To question the established understanding of ROS involvement in diabetes complications.
- To explore new therapeutic targets beyond superoxide anion suppression.
Main Methods:
- Review of cellular and animal studies.
- Analysis of recent findings on superoxide detection in diabetes.
- Focus on novel concepts in ROS signaling in diabetic nephropathy.
Main Results:
- Established view links ROS, particularly superoxide anion, to diabetes complications.
- Recent research challenges the sole focus on superoxide anion, suggesting a need for re-evaluation.
- The complexity of superoxide anion detection in vivo complicates direct attribution of its role.
Conclusions:
- The traditional approach to treating diabetes-related complications by suppressing ROS may need re-evaluation.
- Novel insights into ROS detection suggest a different primary target for diabetic nephropathy.
- Further research is needed to understand the nuanced role of ROS in diabetes and its complications.
More Related Videos
14:25Quantification of Reactive Oxygen Species Using 2′,7′-Dichlorofluorescein Diacetate Probe and Flow-Cytometry in Müller Glial Cells
Published on: May 13, 2022
10:31Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice
Published on: May 2, 2025
Related Concept Videos
Diabetic Nephropathy
Diabetic Retinopathy
Diabetic Neuropathy
Bioactivation and Tissue Toxicity
Diabetic Ketoacidosis ll: Pathophysiology
Type II Diabetes II: Pathophysiology